Skip to main content
OpenTrials
Completed

NCT Number: NCT02162056

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • coronary artery disease
  • implantation of at least one bioresorbable vascular scaffold

Exclusion criteria

  • no written informed consent

Treatment and study plan

use of bioresorbable vascular scaffolds

Device

Implantation of bioresorbable vascular scaffolds for coronary artery disease.

Primary outcomes

  1. Major Adverse Cardiac Events

    Time frame: 10 years

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Acronym: CSI-Ulm-BVS

Important dates

Study start
2013
Primary completion
2018
Study completion
2018
First posted
Jun 12, 2014
Registry last updated
Apr 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.